French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change
Aurélie Aquizerate(Centre Hospitalier Universitaire de Nantes), Caroline Victorri‐Vigneau(Université de Tours), Marie Gérardin(Nantes Université), Morgane Rousselet(Université de Tours), Bruno Revol(Centre Hospitalier Universitaire de Grenoble), Fréderic Libert(Université Clermont Auvergne), Céline Eiden(Centre Hospitalier Universitaire de Montpellier), Amélie Daveluy(Centre Hospitalier Universitaire de Bordeaux), Leïla Chaouachi, Anne‐Sylvie Caous(Hôpital Fernand-Widal), Maryse Lapeyre‐Mestre(Université Fédérale de Toulouse Midi-Pyrénées), Edouard‐Jules Laforgue(Université de Tours), Christine Fournier-Choma(Centre d’Investigation Clinique Innovation Technologique de Nancy), Marion Istvan(Université de Tours), Clémence Lacroix(Inserm), Émilie Jouanjus(Centre Hospitalier Universitaire de Toulouse), Cécile Chevallier(Hospices Civils de Lyon), Valérie Gibaja(Centre Hospitalier Régional et Universitaire de Nancy), Marylène Guerlais(Université de Tours), Bernard Fauconneau, Reynald Le Boisselier(Centre Hospitalier Universitaire de Caen Normandie)
Cited by 6
Related Papers
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
|Journal of the Neurological Sciences|2019|60
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48
Non-targeted screening for novel psychoactive substances among agitated emergency department patients
|Clinical Toxicology|2016|42